Form 4: Revelation Biosciences Director Acquires Shares

Jennifer Carver, a director at Revelation Biosciences, acquired 181 shares of common stock at $3.87 per share on February 11, 2025.

Summary

• On February 11, 2025, Jennifer Carver, a director of Revelation Biosciences, Inc. (REVB), acquired 181 shares of common stock.
• The shares were acquired at a price of $3.87 per share.
• Following the transaction, Ms. Carver directly owns 187 shares of Revelation Biosciences, Inc.
• The acquisition was a Restricted Stock Grant under the 2021 Equity Incentive Plan and vests 100% on the date of grant.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock acquisition. While insider buying can be seen as a positive signal, the small number of shares acquired doesn't suggest a strong conviction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Revelation Biosciences, REVB, insider trading, Form 4, Jennifer Carver, stock acquisition, director, equity incentive plan, restricted stock